Литература

Поставить закладку

Аксель Е.М. Состояние онкологической помощи населению России стран СНГ в 2007 году // Вестник Российского онкологического научного центра им. Н.Н. Блохина РАМН. – 2009. – № 3 (прил. 1) – С. 7–51.
Берзин С.А., Демидов С.М. Возможен ли контроль смертности от рака молочной железы? // Материалы 1-й Всероссийской научно-практической конференции с международным участием «Актуальные вопросы маммологии». – 2001. – С. 31.
Дыхно Ю.А., Черненко О.Н. Диагностика рака молочной железы в республике Хакасия // Сибирский онкологический журнал. – 2008. – Приложение № 2 – С. 44–45.
Захарова Н.А., Котляров Е.В. Опыт организации скрининговых мероприятий по ранней диагностике рака молочной железы в условиях северных регионов России. Российский онкологический журнал. 2010. № 3, С. 31–32.
Захарова Н.А., Duffy S.W., Mackay J., Котляров Е.В. Оценка качества скрининговой программы по ранней диагностике рака молочной железы в Ханты-Мансийском Автономном Округе – Югре. 2010 – Вопросы онкологии 2010. № 5, С. 609–612
Захарова Н.А. Рентгенологическая плотность молочных желез, как фактор риска развития рака молочной железы. Креативная хирургия и онкология. 2012. – № 4. С. 52–58.
Захарова Н.А., Семиглазов В.Ф., Duffy S.W. Скрининг рака молочной железы: Проблемы и решения. Москва. – М.: ГЭОТАР-Медиа, 2011. 176 С.
Иванов О.А. Основные приоритеты противораковой борьбы на современном этапе. Современные технологии в онкологии // Материалы VI Всероссийского съезда онкологов. Ростов-на-Дону. – 2005. – С. 6–17.
Каприн А.Д., Старинский В.В., Алексеева Г.С., Балашов П.Ю. Внедрение порядка оказания медицинской помощи населению по профилю «онкология». Совершенствование структурной и кадровой политики онкологической службы // Вестник Росздравнадзора, 2013. – N 5. – С. 9–13.
Кулигина Е.Ш. Эпидемиологические и молекулярные аспекты рака молочной железы // Практическая онкология. – 2010. – № 4 – С. 203–216.
Летягин В.П. Первичные опухоли молочной железы/Практическое руководство по лечению. – М, 2004. – 332 с.
Мирошниченко А.С. Электроника и связь // Тематический выпуск «Электроника и нанотехнологии». – 2009. – № 1 – С. 147–153.
Моисеенко В.М., Семиглазов В.Ф. Кинетические особенности роста рака молочной железы и их значение для раннего выявления опухоли // Маммология. – 1997. – № 3 – C. 3–12.
Петрова Г.В., Старинский В.В., Грецова О.П., Харченко Н.В. Распространенность, диагностика и лечение злокачественных новообразований в России // Здравоохранение Чувашии. – 2008. – № 3 – С. 56–60.
Портной Л.М., Круглов Е.Е., Полякова О.В., Будникова Н.В. К вопросу о методике и роли скрининга рака молочных желез в консультативных поликлинических отделениях лечебных комплексов регионального уровня // Медицинская визуализация. – 2004. – № 3 – С. 39–45.
Приходченко В.В. Совершенствование организационных форм ранней диагностики и диспансеризации больных с заболевания молочной железы // Вестник гигиены и эпидемиологии. – 2006. – № 1 – С. 152–158.
Рожкова Н.И. Скрининг рака молочной железы // Уральский медицинский журнал. – 2008. – № 11 (51) – С. 46–50.
1Семиглазов В.В., Топузов Э.Э. Рак молочной железы/Под ред. Семиглазова В.Ф. – М.: Медпресс&информ, 2009. –172 c.
Семиглазов В.Ф., Семиглазов В.В. Скрининг рака молочной железы // Практическая онкология. – 2011. – № 2 – С. 60–65.
Семиглазов В.Ф.: Скрининг для раннего выявления рака молочной железы // Медицинский альманах. – 2008. – № 4 – C. 63–65.
Старинский В.В., Ковалёв Б.Н., Пак Д.Д. и др. II Актуальные вопросы маммологии // Материалы межрегиональной научно-практической конференции. Барнаул. – 2001. – С. 221–225.
Хасанов Р.Ш., Шакиров К.Т., Гилязутдинов И.А., Нагуманов Э.В. Организационные методики снижения смертности от злокачественных новообразований визуальных локализаций // Поволжский онкологический вестник. – 2010. – № 1 – С. 7–12.
Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2004 г – М., 2006.
Anderson H et al. Familial Breast and Ovarian Cancer: A Swedish Population- based Register Study // American Journal of Epidemiology. – 2000. – 152. – P. 1154– 1163.
Anderson E., Berg J., Black R. et al. Predicting breast cancer risk: implications of a «weak» family history // Familial Cancer. – 2008. – № 4 – P. 361–366.
Antoniou A., Pharoah P.D., Narod S. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies // American Journal of Human Genetics. – 2003. – № 72 – P. 1117–1130.
Blanks R.J., Moss S.M., Wallis M.G. Use of two-view mammography compared with one view on small invasive cancers: further results from the National Health Service Breast Cancer Screening Programme // Journal of Medical Screening. – 1997. – № 2 – P. 98– 101.
Blanks R.J., Wallis M.G., Moss S.M. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service Breast Cancer Screening Programme // Journal of Medical Screening. – 1998. – № 5 – P. 195–201.
Boyd N.F., Byng J.W., Jong R.A., Fishell E.K., et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study // Journal of National Cancer Institute. – 1995. – № 87 – P. 670–675.
Boyd N.F., Guo H., Martin L.J., Sun L. et al. Mammographic density and the risk and detection of breast cancer // New England Journal of Medicine. – 2007. – № 356 – P. 227–236.
Boyd N.F., Lockwood D.A., Byng J.W., Tritchler D.L., Yaffe M.J. Mammographic densities and breast cancer risk // Cancer Epidemiology and Biomarkers Prevention. – 1998. – № 7 – P. 1133–1144.
Breast Cancer Research UK incidence and mortality statistics http://info.cancerresearchuk.org/cancerstats/ types/breast/incidence/
Buist D.S., Porter P.L., Lehman C. et al. Factors contributing to mammography failure in women aged 40–49 years // Journal of National Cancer Institute. –2004. – № 96 – P. 1432–1440.
Byrne C., Schairer C., Wolfe J., Parekh N. et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status // Journal of National Cancer Institute. – 1995. – № 87 – P. 1622– 1629.
Clark R.L., Copeland M.M., Egan R.L. et al. Reproducibility of the technique of mammography (Egan) for cancer of the breast / Am J Surg. 1965. – № 109 – P. 127–133.
Duffy SW, Chen THH, Yen AMF, et al. Methodologic Issues in the Evaluation of Service Screening // Seminar in Breast Disease. 2007. – № 10 – P. 68–71.
Duffy SW, Hill C, Esteve J. Quantitative Methods for the Evaluation of Cancer Screening. London: Arnold, 2001. P 6.
Duffy SW, Hill C, Esteve J. Quantitative Methods for the Evaluation of Cancer Screening. London: Arnold, 2001. P 8
Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr.
Fischer C., Kuchenbäcker K., Engel C., Zachariae S.: German Consortium for Hereditary Breast and Ovarian Cancer: Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium // J Med Genet. – 2013. – 50 – P. 360–367.
Ford D., Easton D.F., Stratton M. et al. Genetic heterogeneity and penetrance analysis of BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium //American Journal of Human Genetics. – 1998. – № 3 – P. 676–689.
Gail M.H., Brinton L.A., Byar D.P. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually // Journal of National Cancer Institute. – 1989. – № 81 – P. 1879–1886.
Gilbert F.J., Warren R.M. L., Kwan- Lim G., Thompson D.J. Cancers in BRCA1 and BRCA2 Carriers and in Women at High Risk for Breast Cancer: MR Imaging and Mammographic Features // Radiology. – 2009. – № 252 – P. 358–368.
Glide C., Duric N., Littrup P. Novel approach to evaluating breast density utilizing ultrasound tomography // Medical Physics. – 2007. – № 34 – P. 744–753.
Goodwin P.J. Management of familial breast cancer risk // Breast Cancer Research and Treatment. – 2000. – № 1 – P. 19–33.
Harris R.E., Lynch H.T., Guirgis H.A. Familial breast cancer: risk to the contralateral breast // Journal of National Cancer Institute. – 1978. – № 5 – P. 955–960.
Harris H, Nippert 48 I, Julian-Reynier C, Schmidtke J, et al. Familial breast cancer: is it time to move from a reactive to a proactive role? // Cancer. – 2011. – Sep;10 (3) – P. 501–348
IARC Handbooks of Cancer Prevention: Breast Cancer Screening. – Lyon, France: IARC Press, 2002. – 229 p.
Li T., Sun L., Miller N. et al. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer // Cancer Epidemiology and Biomarkers Prevention. – 2005. – № 14 – P. 343–349.
Lip G., Zakharova N., Duffy S.W. et al. Breast density as a predictor of breast cancer risk // Breast Cancer Research. – 2010. – № 12 (3) – P1doi:10.1186/bcr2654
Malone K.E., Begg C.B., Haile R.W. et al. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2 // Journal of Clinical Oncology. – 2010. – № 14 – P. 2404–2410.
Mandelblatt J.S., Cronin K.A., Bailey S. et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Bene ts and Harms // Annals of Internal Medicine. – 2009. – № 10 – P. 738–747.
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Independent UK Panel on Breast Cancer Screening // Lancet. – 2012. – Nov 17;380 (9855). – P. 1778–86. doi: 10.1016/S0140–6736 (12) 61 611–0.
Martin L.J., Melnichouk O., Guo H. et al. Family History, Mammographic Density, and Risk of Breast Cancer // Cancer Epidemiology and Biomarkers Prevention. – 2010. – № 19 (2) – P. 456–463.
Mattsson A, Leitz W, Rutqvist LE. Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life // British Journal of Cancer. – 2000. -;82 (1). – P. 220– 226.
Miglioretti D.L., Walker R., Weaver D.L. et al. Accuracy of Screening Mammography Varies by Week of Menstrual Cycle // Radiology. – 2011. – № 258 – P. 372–379.
Michaelson JS, Satija S, Kopans D, et al. Gauding the Impact of Breast Carcinoma Screening in Terms of Tumor Size and Death Rate // Cancer. 2003. – № 10 – P. 2114–2124.
Moss SM, Michel M, Patnick J, Blanks R, et al: Results from the NHS breast screening programme 1990–1993 // Journal of Medical Screening. 1995. – № 2 – P. 186–190.
Nathanson K.L., Weber B.L. «Other» breast cancer susceptibility genes: searching for more holy grail // Human Molecular Genetics. – 2001. – № 7 – P. 715–720.
Passaperuma K., Warner E., Hill K.A. et al. Is Mammographic Breast Density a Breast Cancer Risk Factor in Women With BRCA Mutations? // Journal of Clinical Oncology. – 2010. – № 23 – P. 3779–3783.
Patnick J. NHS Breast Screening: the progression from one to two views // Journal of Medical Screening. – 2004. – № 11 – P. 55–56.
Perry N, Broeders M, de Wolf C, et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition, 2006. P 11–14.
Pruthi S., Gostout B.S., Lindor N.M. Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer // Mayo Clinic Proceedings. – 2010. – № 12 – P. 1111–1120.
Qaseem A., Snow V., Sherif K., Aronson M., et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians // Annals of Internal Medicine. – 2007. – № 146–511– 515.
Ren B., Smith A.P., Marshall J. Investigation of Practical Scoring Methods for Breast Density // Lecture Notes in Computer Science. – 2010. – № 6136 – P. 651–658
66. Schousboe J.T., Kerlikowske K., Loh A. Cummings S.R. Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness // Annals of Internal Medicine. – 2011. – № 1 – P. 10–20.
Smith RA, Duffy SW, Gabe R, et al. The randomised trials of breast cancer screening what have we learned // Radiol Clin N Am. 2004 – № 42 – P. 793–806.
Stone J., Warren R.M., Pinney E. et al. Determinants of percentage and area measures of mammographic density // American Journal of Epidemiology. – 2009. – № 170 – P. 1571– 1578.
Tabar L, Fagerberg CJG, Duffy S, et al. Update of the Swedish two-country program of mammographic screening for breast cancer // Radiol Clin N Am. 1992 – № 1 – P. 187–209.
Tice J.A., Cummings S.R., Smith- Bindman R., Ichikawa L. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model // Annals of Internal Medicine. – 2008. – № 5 – P. 337–347.
Tice JA, O»Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer // J Natl Cancer Inst. – 2013. – Jul 17;105 (14). – P. 1043–9.
Torres-Mejia G., De Stavola B., Allen D.S., Perez-Gavilan J.J., et al. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies // Cancer Epidemiology and Biomarkers Prevention. – 2005. – № 14 – P. 1052–1059.
Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors // Stat Med. – 2004. – 23. – P. 1111–1130.
U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement // Annals of Internal Medicine. – 2009. – 151 (10) – P. 716–726.
Ursin G., Ma H., Wu A.H., Bernstein L., et al. Mammographic density and breast cancer in three ethnic groups // Cancer Epidemiology and Biomarkers Prevention. – 2003. – № 12 – P. 332–338.
Vachon C.M., Brandt K.R., Ghosh K., Scott C.G., et al. Mammographic breast density as a general marker of breast cancer risk // Cancer Epidemiology and Biomarkers Prevention. – 2007. – № 16 – P. 43–49.
Vachon C.M., Pankratz V.S., Scott C.G. et al. Longitudinal trends in Mammographic percent density and breast cancer risk // Cancer Epidemiology and Biomarkers Prevention. – 2007. – № 16 – P. 921–928.
Wai E.S., D»yachkova Y., Olivotto I.A. et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography // British Journal of Cancer. – 2005. – № 92 – P. 961–966.
Wald N.J., Murphy P., Major P. et al. UKCCCR multicentre randomized control trial of one and two view mammography in breast cancer screening // British Medical Journal. – 1995. – № 311 – P. 1189–1193.
Walsh T., Casadei S., Coats K.H. et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in families at high risk of breast cancer // JAMA. – 2006. – № 12 – P. 1379–1388.
Warren R, Duffy SW. Interval cancers as an indicator of performance in breast screening // Breast Cancer. 2000. – № 7 – P. 9–18.
Wei J., Chan H.P., Wu Y.T., Zhou C. Association of Computerized Mammographic Parenchymal Pattern Measure with Breast Cancer Risk: A Pilot Case-Control Study // Radiology. – 2011. – № 260 – P. 42–49.
Weir R., Day P., Ali W. Risk factors for breast cancer in women. A systematic review of the literature //NZHTA REPORT. – 2007. – № 2 – P. 29–34.
White E., Miglioretti D.L., Yankaskas B.C. et al. Biennial versus annual mammography and the risk of late-stage breast cancer // Journal of National Cancer Institute. – 2004. – № 96 – P. 1832–1839.
Wong C.S., Lim G.H., Gao F. et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population // British Journal of Cancer. – 2011 – № 1 – P. 1–4.
Yaffe MJ, Mainprize JG. Risk of radiation- induced breast cancer from mammographic screening // Radiology. – 2011. – - 258 (1). – P. 98–105.